The General Assembly of the European Association for the Study of the Liver (EASL) has elected new members to its Governing Board, various committees and a new Editor-In-Chief for its Journal of Hepatology. 12 April 2019 - Vienna, Austria The…
New research, presented at the International Liver Congress™, warns that high levels of non-alcoholic fatty liver disease among young people is signalling a public health crisis. Excerpt from The Guardian Study finds substantial numbers of young people at risk of…
The latest journal from EASL, JHEP Reports is fully open access.Our goal is to become an essential channel for innovation in hepatology by publishing outstanding basic, translational and clinical studies.
It is estimated that 2 billion people are infected with hepatitis B virus (HBV) globally, with 686,000 people dying from complications of the disease each year.
Hepatic encephalopathy (HE) is a frequent complication in patients with chronic liver disease. HE is a complication of cirrhosis that is associated with psychomotor slowing and an increased risk of accidents at home, at work, or while driving a car…
Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients…
Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was…
DIGESTIVE WELLNESS 14 December 2018 170,000 people in Europe die from liver failure every year. The cirrhosis death toll could be cut from 2020, thanks to advanced dialysis technology being trialled in the UK and Europe now. Many people with…
Alcoholic liver disease and nonalcoholic fatty liver disease (NAFLD) are the leading etiologies for chronic liver disease chronic-liver-disease-related deaths in the United States over the last decade, according to the results of a new study. The prevalence of nonalcoholic fatty…
Perspectum Diagnostics released details regarding the latest version of its LiverMultiScan magnetic resonance imaging technology which identified nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, according to a press release. The latest version of LiverMultiScan, known as LiverMultiScan IDEAL, will feature…